Effectiveness and efficiency of intensive care medicine: variable costs in different diagnosis groups
Authors:
- G. IapichinoGIG. Iapichino
- C. RossiCRC. Rossi
- L. BrazziL. Brazzi
- R. MelottiRMR. Melotti
- for the GiViTI group (Italian Group for the Evaluation of Interventions in Intensive Care Medicine)FMfor the GiViTI group (Italian Group for the Evaluation of Interventions in Intensive Care Medicine)
- 9 June 2004
- journal article
- research article
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 48 (7) , 820-826
Abstract
Background: To establish the effectiveness of ICU treatment and the efficiency in the use of resources in patients stratified according to 10 diagnosis and two levels‐of‐care. To propose strategies aimed at reducing costs and improving efficiency in each patient group.Methods: Multicentre prospective observational study. ICUs enrolled two cohorts of up to 10 consecutive patients with ICU stay ≥48 h. Each with one of these diagnoses: trauma, brain‐trauma, brain‐hemorrhage, stroke, acute‐on‐chronic‐obstructive‐pulmonary disease, lung‐injury/acute respiratory distress syndrome, heart failure, and scheduled/unscheduled abdominal surgery. The presence of active‐life support divides high from low level‐of‐care treatments. Variable ICU costs were collected daily (bottom‐up) for 21 days. We evaluated effectiveness (hospital survival) and efficiency (hospital‐survivors variable‐cost as a ratio of overall cost).Results: Forty‐two Italian general ICUs recruited 529 patients in 5 months. Mean ICU variable‐costs significantly differed with diagnosis and level‐of‐care. Costs were positively affected by ICU length‐of‐stay, by duration of active‐treatment. Outcome variably influenced costs. Medians of variable‐costs per patient (1715 Euro) and patient‐groups efficiencies (60.7%) identified four possible combinations between (low and high) cost and (low and high) efficiency groups. Moreover, efficiency was better than effectiveness in stroke, brain‐hemorrhage and trauma, while it was worse in heart failure, acute‐on‐COPD or acute‐lung injury. Overall ICU cost attributed only to survivors ranged from 699 (scheduled surgical) to 5906 (unscheduled surgical) Euro. Cost of non‐survivors distributed to all patient was between 95 (scheduled‐surgical) to 1633 (unscheduled‐surgical) Euro.Conclusions: Analysis of variable patient‐specific cost was used as a tool to assess intensive care performance in patient subgroups with different diagnosis and levels‐of‐care.Keywords
This publication has 15 references indexed in Scilit:
- Determinants of post-intensive care mortality in high-level treated critically ill patientsIntensive Care Medicine, 2003
- Description of trends in the course of illness of critically ill patients. Markers of intensive care organization and performanceIntensive Care Medicine, 2002
- Understanding Costs and Cost-Effectiveness in Critical Care: Report from the Second American Thoracic Society Workshop on Outcomes ResearchAmerican Journal of Respiratory and Critical Care Medicine, 2002
- A cost-effectiveness analysis of stays in intensive care unitsIntensive Care Medicine, 2001
- The performance of SAPS II in a cohort of patients admitted to 99 Italian ICUs: results from GiViTIIntensive Care Medicine, 1996
- The economics and cost-effectiveness of critical care medicineIntensive Care Medicine, 1995
- A method for assessing the clinical performance and cost-effectiveness of intensive care unitsCritical Care Medicine, 1994
- Scoring systems and the measurement of icu cost effectivenessRéanimation Urgences, 1994
- A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter studyJAMA, 1993
- Management control in the ICU1990